On July 31, 2025, Silexion Therapeutics Corp. entered into an inducement offer letter agreement with certain holders of 152,106 existing warrants. These warrants, originally issued in January 2025, were exercised for cash at a reduced price of $11.57 per share. In return, Silexion agreed to issue new warrants for 304,212 ordinary shares at an exercise price of $11.32 per share. The company anticipates gross proceeds of approximately $1.8 million from the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silexion Therapeutics Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-25-002570), on August 01, 2025, and is solely responsible for the information contained therein.